263 related articles for article (PubMed ID: 36439506)
1. Dynamic FDG-PET imaging for differentiating metastatic from non-metastatic lymph nodes of lung cancer.
Wumener X; Zhang Y; Wang Z; Zhang M; Zang Z; Huang B; Liu M; Huang S; Huang Y; Wang P; Liang Y; Sun T
Front Oncol; 2022; 12():1005924. PubMed ID: 36439506
[TBL] [Abstract][Full Text] [Related]
2. The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.
Wumener X; Zhang Y; Zang Z; Du F; Ye X; Zhang M; Liu M; Zhao J; Sun T; Liang Y
BMC Pulm Med; 2024 May; 24(1):227. PubMed ID: 38730287
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity Analysis of (18)F-FDG Uptake in Differentiating Between Metastatic and Inflammatory Lymph Nodes in Adenocarcinoma of the Lung: Comparison with Other Parameters and its Application in a Clinical Setting.
Budiawan H; Cheon GJ; Im HJ; Lee SJ; Paeng JC; Kang KW; Chung JK; Lee DS
Nucl Med Mol Imaging; 2013 Dec; 47(4):232-41. PubMed ID: 24900118
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic ability of
Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
[TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Metastatic Mediastinal Lymph Nodes of Non-Small Cell Lung Cancer on Preoperative F-18 FDG PET/CT.
Lee AY; Choi SJ; Jung KP; Park JS; Lee SM; Bae SK
Nucl Med Mol Imaging; 2014 Mar; 48(1):41-6. PubMed ID: 24900137
[TBL] [Abstract][Full Text] [Related]
8. Quantitative parameters of static imaging and fast kinetics imaging in
Meng N; Zhang M; Ren J; Fu F; Xie B; Wu Y; Li Z; Dai B; Li Y; Feng T; Xu T; Wang M
Quant Imaging Med Surg; 2023 Sep; 13(9):5579-5592. PubMed ID: 37711783
[TBL] [Abstract][Full Text] [Related]
9. Preliminary clinical assessment of dynamic
Shinya T; Otomi Y; Kubo M; Kinoshita M; Takechi K; Uyama N; Yamanaka M; Terazawa K; Toba H; Bando Y; Otsuka H; Harada M
Ann Nucl Med; 2019 Jun; 33(6):414-423. PubMed ID: 30911883
[TBL] [Abstract][Full Text] [Related]
10. The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients.
Choi EK; Park HL; Yoo IR; Kim SJ; Kim YK
Eur Radiol; 2020 Jan; 30(1):442-451. PubMed ID: 31338654
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
[TBL] [Abstract][Full Text] [Related]
12. Correlation Between SUVmax and CT Radiomic Analysis Using Lymph Node Density in PET/CT-Based Lymph Node Staging.
Giesel FL; Schneider F; Kratochwil C; Rath D; Moltz J; Holland-Letz T; Kauczor HU; Schwartz LH; Haberkorn U; Flechsig P
J Nucl Med; 2017 Feb; 58(2):282-287. PubMed ID: 27660141
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of dynamic
Sun Y; Xiao L; Wang Y; Liu C; Cao L; Zhai W; Wang B; Yu S; Xin J
Quant Imaging Med Surg; 2023 Apr; 13(4):2556-2567. PubMed ID: 37064404
[TBL] [Abstract][Full Text] [Related]
14. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
Shigemoto Y; Suga K; Matsunaga N
Ann Nucl Med; 2016 May; 30(4):287-97. PubMed ID: 27007128
[TBL] [Abstract][Full Text] [Related]
15. Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
Mattes MD; Moshchinsky AB; Ahsanuddin S; Rizk NP; Foster A; Wu AJ; Ashamalla H; Weber WA; Rimner A
Clin Lung Cancer; 2015 Nov; 16(6):e253-8. PubMed ID: 26163919
[TBL] [Abstract][Full Text] [Related]
16. Value of [
Deleu AL; Laenen A; Decaluwé H; Weynand B; Dooms C; De Wever W; Jentjens S; Goffin K; Vansteenkiste J; Van Laere K; De Leyn P; Nackaerts K; Deroose CM
EJNMMI Res; 2022 May; 12(1):28. PubMed ID: 35524900
[TBL] [Abstract][Full Text] [Related]
17. Ratio of Mediastinal Lymph Node SUV to Primary Tumor SUV in
Cho J; Choe JG; Pahk K; Choi S; Kwon HR; Eo JS; Seo HJ; Kim C; Kim S
Nucl Med Mol Imaging; 2017 Jun; 51(2):140-146. PubMed ID: 28559938
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of
Cha J; Kim S; Wang J; Yun M; Cho A
Nucl Med Mol Imaging; 2018 Feb; 52(1):39-45. PubMed ID: 29391911
[TBL] [Abstract][Full Text] [Related]
19. Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients?
Simsek FS; Comak A; Asik M; Kuslu D; Balci TA; Ulutas H; Koroglu R; Kekilli E; Akatli A; Elmali F; Yalcin NC; Akyol H
Niger J Clin Pract; 2020 Jun; 23(6):842-847. PubMed ID: 32525121
[TBL] [Abstract][Full Text] [Related]
20. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
